Literature DB >> 10906100

Expression of VLA-2, VLA-3, and alpha(v) integrin receptors in uveal melanoma: association with microvascular architecture of the tumour and prognostic value.

G Anastassiou1, H Schilling, S Djakovic, N Bornfeld.   

Abstract

BACKGROUND: The interaction of the integrin receptors with their ligands (collagen, laminin, fibronectin, and others) has a crucial role during the reorganisation of the extracellular matrix and the metastatic process. The presence of particular vascular patterns in uveal melanoma is associated with the development of metastases. There is some evidence that interactions between the tumour cells and the extracellular matrix are responsible for the shape of these patterns.
METHODS: The expression of VLA-2, VLA-3, and alpha(v) integrin receptors was examined by immunohistochemistry on paraffin embedded tumour specimens from 92 uveal melanomas (iris melanomas excluded). Possible correlations between these results and the tumour vascular patterns, the histological features of the tumours as well as the clinical outcome of the patients, were investigated.
RESULTS: The expression of VLA-2 in tumours was associated with the presence of vascular networks (p = 0.05). Tumours with less than 25% VLA-3 positive cells infiltrated the sclera more frequently than those with more than 25% VLA-3 cell positivity (p = 0.05). Tumours expressing less than 50% alpha(v) positive cells were associated with the mixed or epithelioid cell type (p = 0.05) and, with less statistical precision, with the presence of extraocular growth (p = 0.07). The univariate logistic regression analysis showed that the risk of developing metastases within the first 5 years after diagnosis did not depend on the expression of the integrin receptors investigated.
CONCLUSION: The potential biological importance of the associations between integrin expression and the histopathological features of the tumours found in the present study remains to be elucidated in future experiments. The immunohistochemical detection of VLA-2, VLA-3, and alpha(v) integrins had no prognostic value in our preliminary report.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10906100      PMCID: PMC1723581          DOI: 10.1136/bjo.84.8.899

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  24 in total

Review 1.  The microcirculation of choroidal and ciliary body melanomas.

Authors:  R Folberg; M Mehaffey; L M Gardner; M Meyer; V Rummelt; J Pe'er
Journal:  Eye (Lond)       Date:  1997       Impact factor: 3.775

Review 2.  Integrins: versatility, modulation, and signaling in cell adhesion.

Authors:  R O Hynes
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

3.  Uveal melanoma: the importance of large nucleoli in predicting patient outcome--an automated image analysis study.

Authors:  I W McLean; M E Sibug; R L Becker; J B McCurdy
Journal:  Cancer       Date:  1997-03-01       Impact factor: 6.860

4.  Prognostic implications of monosomy 3 in uveal melanoma.

Authors:  G Prescher; N Bornfeld; H Hirche; B Horsthemke; K H Jöckel; R Becher
Journal:  Lancet       Date:  1996-05-04       Impact factor: 79.321

5.  Premetastatic uveal melanoma cells do not express laminin receptors.

Authors:  J M Rohrbach; M Wild; C Riedinger; I Kreissig; H J Thiel
Journal:  Ger J Ophthalmol       Date:  1994-05

6.  A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988.

Authors:  M Diener-West; B S Hawkins; J A Markowitz; A P Schachat
Journal:  Arch Ophthalmol       Date:  1992-02

7.  Investigation of the role of signal transduction in attachment of ocular melanoma cells to matrix proteins: inhibition of attachment by calmodulin antagonists including tamoxifen.

Authors:  S Mac Neil; M Wagner; I G Rennie
Journal:  Clin Exp Metastasis       Date:  1994-11       Impact factor: 5.150

8.  Expression of type VI collagen in uveal melanoma: its role in pattern formation and tumor progression.

Authors:  K J Daniels; H C Boldt; J A Martin; L M Gardner; M Meyer; R Folberg
Journal:  Lab Invest       Date:  1996-07       Impact factor: 5.662

9.  Identification of a melanoma progression antigen as integrin VLA-2.

Authors:  C E Klein; T Steinmayer; D Kaufmann; L Weber; E B Bröcker
Journal:  J Invest Dermatol       Date:  1991-02       Impact factor: 8.551

10.  Tumor progression in human malignant melanoma is associated with changes in alpha 6/beta 1 laminin receptor.

Authors:  P G Natali; M R Nicotra; R Cavaliere; D Giannarelli; A Bigotti
Journal:  Int J Cancer       Date:  1991-09-09       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.